What is the price target for GUTS stock?
11 analysts have analysed GUTS and the average price target is 5.34 USD. This implies a price increase of 1072.36% is expected in the next year compared to the current price of 0.4559.
FRACTYL HEALTH INC (GUTS) Forecast, Price Target & Analyst Ratings
NASDAQ:GUTS • US35168W1036
Current stock price
0.4559 USD
-0.01 (-1.89%)
At close:
0.4467 USD
-0.01 (-2.02%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FRACTYL HEALTH INC (GUTS).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.16
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.34
Upside
+ 1,072.36%
From current price of $0.46 to mean target of $5.34, Based on 11 analyst forecasts
Low
$2.02
Median
$6.32
High
$8.40
Price Target Revisions
1 Month
0.00%
3 Months
-29.57%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for GUTS. The average price target is 5.34 USD. This implies a price increase of 1072.36% is expected in the next year compared to the current price of 0.4559.
The average price target has been revised downward by 29.57% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.64%
GUTS was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about GUTS.
In the previous month the buy percentage consensus was at a similar level.
GUTS was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-01-30 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-12-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-15 | HC Wainwright & Co. | Initiate | Buy |
| 2025-08-28 | Ladenburg Thalmann | Initiate | Buy |
| 2025-08-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-15 | Canaccord Genuity | Initiate | Buy |
| 2025-02-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-02-28 | Evercore ISI Group | Initiate | Outperform |
| 2024-02-27 | Morgan Stanley | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.16
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 67.39%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-7.14%
Next Earnings Summary
GUTS is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.16 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 120K | 93K -22.50% | -100.00% | 22.772M | 119.58M 425.12% | 257.54M 115.37% | 470.68M 82.76% | |||
| EBITDA YoY % growth | -48.933M -34.98% | -50.55M -3.30% | -92.854M -83.69% | -97.512M -5.02% | -96.074M 1.47% | -98.056M -2.06% | -12.648M 87.10% | 81.702M 745.97% | 218.28M 167.17% | |
| EBIT YoY % growth | -49.385M -33.73% | -50.836M -2.94% | -93.531M -83.99% | -98.056M -4.84% | -99.36M -1.33% | -88.749M 10.68% | -59.514M 32.94% | 17.432M 129.29% | 144.66M 729.85% | |
| Operating Margin | N/A | -42,363.33% | -100,570.97% | N/A | N/A | -389.73% | -49.77% | 6.77% | 30.73% | |
| EPS YoY % growth | N/A | N/A | -1.53 95.50% | -1.64 -5.88% | -0.70 56.56% | -0.66 6.16% | -0.38 41.82% | 0.05 112.40% | 0.57 1,099.14% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 67.39% | -0.16 72.56% | -0.16 77.97% | -0.15 -202.00% | -0.22 -40.42% | -0.22 -43.48% | -0.21 -36.96% | -0.19 -26.67% |
| Revenue Q2Q % growth | 1.53M | 3.57M | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.266M 1.99% | -24.103M 7.58% | -23.899M -5.31% | -23.552M 5.04% | -24.704M -1.81% | -24.837M -3.05% | -23.746M 0.64% | -22.256M 5.50% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.80%
EPS Next 5 Year
18.66%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-3.57%
EBIT Next 5 Year
23.95%
FRACTYL HEALTH INC / GUTS Forecast FAQ
What is the next earnings date for GUTS stock?
FRACTYL HEALTH INC (GUTS) will report earnings on 2026-05-12.
What are the consensus estimates for FRACTYL HEALTH INC (GUTS) next earnings?
The consensus EPS estimate for the next earnings of FRACTYL HEALTH INC (GUTS) is -0.16 USD and the consensus revenue estimate is 0 USD.
How many analysts cover FRACTYL HEALTH INC (GUTS) stock?
The number of analysts covering FRACTYL HEALTH INC (GUTS) is 11.